[1]
“Unsuccessful story of ABT‑639 in Neuropathic Pain in Different Phases of Clinical Trials”, Journal of Pharmaceutical Negative Results, vol. 10, no. 1, pp. 1–5, Jan. 2019, Accessed: Jun. 09, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/131